Trevena Inc (TRVN)
0.4087
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 10:32
Trevena Cash from Financing (TTM): 26.31M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 26.31M |
September 30, 2023 | 30.24M |
June 30, 2023 | 15.56M |
March 31, 2023 | 23.50M |
December 31, 2022 | 23.50M |
September 30, 2022 | 15.28M |
June 30, 2022 | 14.18M |
March 31, 2022 | 5.002M |
December 31, 2021 | 7.734M |
September 30, 2021 | 11.88M |
June 30, 2021 | 72.50M |
March 31, 2021 | 99.25M |
December 31, 2020 | 95.02M |
September 30, 2020 | 89.00M |
June 30, 2020 | 25.21M |
March 31, 2020 | -10.09M |
December 31, 2019 | -2.497M |
September 30, 2019 | -3.525M |
June 30, 2019 | 10.18M |
March 31, 2019 | 20.65M |
December 31, 2018 | 20.60M |
Date | Value |
---|---|
September 30, 2018 | 25.29M |
June 30, 2018 | 20.27M |
March 31, 2018 | 19.92M |
December 31, 2017 | 30.99M |
September 30, 2017 | 49.87M |
June 30, 2017 | 44.44M |
March 31, 2017 | 37.60M |
December 31, 2016 | 32.33M |
September 30, 2016 | 28.32M |
June 30, 2016 | 103.00M |
March 31, 2016 | 119.24M |
December 31, 2015 | 107.58M |
September 30, 2015 | 138.96M |
June 30, 2015 | 65.99M |
March 31, 2015 | 49.80M |
December 31, 2014 | 109.18M |
September 30, 2014 | 62.01M |
June 30, 2014 | 60.23M |
March 31, 2014 | 115.69M |
December 31, 2013 | 55.61M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-10.09M
Minimum
Mar 2020
99.25M
Maximum
Mar 2021
28.85M
Average
15.56M
Median
Jun 2023
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Oragenics Inc | 0.2839M |